Mechanistically, PGC-1α localizes to subnuclear structures, facilitating its interaction with transcriptional cofactors and coregulators, in which the promyelocytic leukemia (PML) nuclear body constitutes an interface whereby PGC-1α interacts with transcriptional components. Here, PPARGC1A is linked to leukemia.